Branded
Legacy, Inc. Expands Operations with Move to State of the Art
Biotech Facility in Melbourne, FL
White Label
Deal Secured, 1,700,000 Preferred Series Shares Repurchased and
Retired
Melbourne, FL -- February 8, 2024 -- InvestorsHub NewsWire
-- (OTC.PK:
BLEG), a prominent
Biotech company, proudly announces a significant leap forward in
its growth journey with the acquisition of a new, state-of-the-art
facility in Melbourne, FL.
In response to the acquisition
of several companies and over $3.7 million worth of advanced scientific
equipment and inventory, Branded Legacy, Inc. has surpassed the
capacity of its current location, prompting the need for a more
expansive and purpose-built space. The new facility in Melbourne,
FL, marks a substantial upgrade that aligns with the company's
commitment to advancing biotechnology and improving human
health.
Key
Highlights of the New Biotech Facility:
Expanded
Space: Boasting an additional 12,100
square feet, the new facility provides Branded Legacy, Inc. with
the necessary space to facilitate its biotech operations
seamlessly.
Efficiency
Redefined: The facility has been
meticulously designed to optimize efficiency, prioritizing
functionality for Branded Legacy, Inc.'s innovative biotech
research and development endeavors.
Cutting-Edge
Infrastructure: Addressing crucial
infrastructure needs, the facility is equipped with advanced
amenities, including specialized laboratories, to support the
company's pioneering work in biotechnology.
Better
Electrical System: At their previous location, the
electrical system was substandard for their needs, and would have
needed an upgrade. This facility has 3 phase and
240 outlets already in place and up to code.
Secure
Private Parking: Recognizing the importance of
security for critical biotech assets, the new facility features
secure private parking tailored for fleet vehicles, including the
recently acquired mobile critical CO2 extraction lab.
Enhanced
Office Space: The facility offers expanded
office space, designed to foster collaboration and innovation among
Branded Legacy, Inc.'s team of biotech professionals.
Impressive
Architecture: Constructed with a focus on
both form and function, the new facility reflects Branded Legacy,
Inc.'s commitment to excellence, presenting an impressive
architectural profile.
"This relocation signifies a
pivotal moment for Branded Legacy, Inc. as we continue to advance
our capabilities in the field of biotechnology," said David Oswald,
CEO of Branded Legacy, Inc. "Our investment in cutting-edge
scientific equipment has catalyzed our growth, and this new
facility reinforces our dedication to advancing biotech solutions
for the betterment of humanity."
The move to the new biotech
facility underlines Branded Legacy, Inc.'s commitment to pushing
the boundaries of biotechnology and
improving the future of healthcare.
In other company news, Branded
Legacy Inc., announces an ongoing partnership with a major
distributor in Greenville South Carolina, marking a significant
milestone in the distribution of Delta 8 gummies. This strategic
collaboration will see Branded Legacy Inc. supplying 7,500 units of
Delta 8 gummies in the initial deal.
The deal, valued at $27,500,
signifies a major step towards meeting the rising demand for Delta
8 gummies in the market. The initial net revenue generated from
this partnership is estimated at $22,015.23, showcasing the immense
potential for growth and mutual success between the two
companies.
The partnership is not just a
one-time deal; it marks the beginning of an ongoing collaboration
between these entities. Both companies are dedicated to fostering a
long-term relationship that goes beyond a single transaction. The
ongoing contract reflects the confidence each party has in the
other's commitment to success and shared values.
As the Delta 8 gummy market
continues to grow, Branded Legacy Inc. is positioned to play a key
role in meeting consumer demands and providing a superior product
in the hemp industry.
Additionally, Branded Legacy has renewed its
commitment to optimizing its capital structure and returning value
to shareholders, Branded Legacy has successfully repurchased
1,700,000 Series D Preferred Shares, which have been subsequently
returned to treasury. This strategic move reflects the company's
confidence in its financial position and its dedication to capital
efficiency.
Presently, there are a total of 3,864,884 remaining
Series D Preferred Shares outstanding. Among this total, 2,000,000
shares were initially issued for the acquisition of MariJ. The
company continues its ongoing efforts to repurchase the remaining
1,864,884 Series D Preferred Shares in order to retire them.
However, negotiations for the repurchase of these preferred shares
have not yet concluded successfully.
As of February 8, 2024, Branded Legacy has
611,913,066 Common Shares Issued and Outstanding. Within this
count, 529,565,857 are unrestricted common shares, while 82,347,209
are classified as restricted common shares.
Branded Legacy remains committed to transparent
communication with its shareholders and will continue to explore
opportunities to optimize its capital structure and create
long-term value for its stakeholders.
Original Copy of
this Press Release:
https://brandedlegacy.com/branded-legacy-inc-expands-operations-with-move-to-state-of-the-art-biotech-facility-in-melbourne-fl
For media inquiries, please
contact:
Investor Relations & Media
Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded
Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a
diversified holdings company focused on the biotech sector. With a
commitment to excellence and innovation, Branded Legacy specializes
in the development and marketing of cutting-edge products and
services. The company's diverse portfolio includes ventures in
biotechnology, digital solutions, and wellness products, all aimed
at enhancing the quality of life for its customers. Branded
Legacy's strategic approach to growth involves identifying and
integrating promising businesses and technologies that align with
its mission to deliver sustainable, high-quality products and
services.
Safe Harbor
Statement on Forward-Looking Language:
This release includes
forward-looking statements, which are based on certain assumptions
and reflect management's current expectations. These
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results or events to differ
materially from current expectations. Some of these factors include
general global economic conditions; general industry and market
conditions and growth rates; uncertainty as to whether our
strategies and business plans will yield the expected benefits;
increasing competition; availability and cost of capital; the
ability to identify and develop and achieve commercial success; the
level of expenditures necessary to maintain and improve the quality
of services; changes in the economy; changes in laws and
regulations, includes codes and standards, intellectual property
rights, and tax matters; or other matters not anticipated; our
ability to secure and maintain strategic relationships and
distribution agreements. Dilution, if any, would be for the
purposes of management taking stock in lieu of cash salary. The
company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise. Additionally, this press
release that is not statements of historical fact may be considered
to be forward-looking statements. Written words such as "may,"
"will," "expect," "believe," "anticipate," "estimate," "intends,"
"goal," "objective," "seek," "attempt," or variations of these or
similar words, identify forward-looking statements. By their
nature, forward-looking statements and forecasts involve risks and
uncertainties because they relate to events and depend on
circumstances that will occur in the near future.
Branded Legacy (PK) (USOTC:BLEG)
Historical Stock Chart
From Oct 2024 to Nov 2024
Branded Legacy (PK) (USOTC:BLEG)
Historical Stock Chart
From Nov 2023 to Nov 2024
